# FDA Inspection 1023320 - Fziomed Inc - August 17, 2017

Source: https://www.keypedia.com/records/fda_inspections/fziomed-inc/76030181-b82b-4c6e-ba3f-7bfb0d1e3585
Source feed: FDA_Inspections

> FDA Inspection 1023320 for Fziomed Inc on August 17, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1023320
- Company Name: Fziomed Inc
- Inspection Date: 2017-08-17
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 889228 - 2014-07-24](https://www.keypedia.com/records/fda_inspections/fziomed-inc/20893a3f-04bb-43ed-9662-a876b65ab329)
- [FDA Inspection 889228 - 2014-07-24](https://www.keypedia.com/records/fda_inspections/fziomed-inc/4debf300-6dbb-4de4-a2b4-ec1fa08a5513)

Company: https://www.keypedia.com/companies/fziomed-inc/7d04d2b9-82fc-4786-babb-57e38150968a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d